Table 1.
Demographic data of patients with positive serum fixed CBA anti-MOG results who were included in this assessment.
| All positive anti-MOG results N = 85 | Low-positive anti-MOG results (Titer < 1:100) N = 47 | Clear-positive anti-MOG results (Titer ≥ 100) N = 38 | p-value* | |
|---|---|---|---|---|
| Median age at time of testing, years (range) | 16.1 (0.2–77.1) | 17.2 (1.1–77.1) | 14.6 (0.2–77.0) | 0.26 |
| Pediatric (%) | 54 (64) | 28 (60) | 26 (68) | 0.50 |
| Female (%) | 41 (48) | 21 (45) | 20 (53) | 0.52 |
*p-value refers to comparison of difference between low-positive and clear-positive anti-MOG results.
CBA, cell-based assay; MOG, myelin oligodendrocyte glycoprotein.